Soft Tissue Sarcoma
📧 Sign up to get email alerts when something new happens for Soft Tissue Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX) [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigating metronomic cyclophosphamide (CP) and JX-594 in patients with advanced breast cancer and advanced so…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: A Public Health Intervention Program to Improve the Initial Management of Soft Tissue Sarcomas.
A completed clinical trial evaluating a public health intervention program aimed at improving the initial management of soft tissue sarcomas…
-
FDA approval · 2021-12-13FDA Approved: VOTRIENT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for VOTRIENT (pazopanib hydrochloride) from Novartis Pharmaceuticals Corporation. Pazopanib is used …
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: A Phase 2 Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue Sarcoma [Phase 2]
Phase 2 clinical study evaluating recombinant anti-PD-1 antibody (609A) with doxorubicin for metastatic/unresectable soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2021-10-11Clinical Trial Update: A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma [Phase 1, Phase 2]
A study of olaratumab (LY3012207) in participants with advanced soft tissue sarcoma completed Phase 1 and Phase 2 trials; results posted in …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-09-22Clinical Trial Update: Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib [Phase 4]
Phase 4 trial evaluating quality of life in soft tissue sarcoma patients receiving palliative chemotherapy or pazopanib was terminated.
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Cabozantinib for Adults With Advanced Soft Tissue Sarcoma [Phase 2]
Phase 2 clinical trial update evaluating cabozantinib in adults with refractory soft tissue sarcomas has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma [Phase 2]
Phase 2 trial investigating camrelizumab plus doxorubicin as first-line treatment for advanced soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies [Phase 2]
Phase 2 trial update evaluating PDR001 plus LAG525 in patients with advanced solid and hematologic malignancies; results posted with complet…
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall [Phase 2, Phase 3]
A Phase 2/3 trial evaluating NBTXR3 crystalline nanoparticles with radiation therapy in adults with soft tissue sarcoma of the extremity and…
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas [Phase 2]
Phase 2 trial update for axitinib in advanced angiosarcoma and other soft tissue sarcomas has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma [Phase 3]
A Phase 3 randomized trial evaluating different volumes of post-operative radiotherapy in adult extremity soft tissue sarcoma has been compl…
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas [Phase 2]
Phase 2 study of TAK-228 (MLN0128) in soft tissue sarcoma was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Pegylated Liposomal Doxorubicin Combined With Anlotinib for Neoadjuvant Treatment of Soft Tissue Sarcoma [Phase 2]
Phase 2 clinical trial evaluating pegylated liposomal doxorubicin plus anlotinib as neoadjuvant therapy for stage III soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma [Phase 2]
Phase 2 trial evaluating gemcitabine with or without pazopanib in refractory soft tissue sarcoma completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas [Phase 2]
Phase 2 clinical trial evaluating hypofractionated radiotherapy with hyperthermia for unresectable or marginally resectable soft tissue sarc…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall [Phase 2]
Phase 2 clinical trial evaluating hypofractionated radiotherapy followed by sequential chemotherapy for marginally resectable soft tissue sa…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Dalteparin in Preventing DVT in Participants With Cancer [NA]
Clinical trial update for dalteparin in preventing DVT in cancer patients; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Patterns of Care and Outcomes in METAstatic Soft Tissue SARComa
The update reports on patterns of care and outcomes for patients with metastatic soft tissue sarcoma in the completed study NCT03977818.
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: Gemcitabine Plus Ascorbate for Sarcoma in Adults [Phase 2]
Phase 2 clinical trial evaluating gemcitabine plus ascorbate in adults with sarcoma; trial status terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-28Clinical Trial Update: Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of High-risk Soft Tissue Sarcoma [Phase 2]
A Phase 2 trial evaluating camrelizumab in combination with neoadjuvant chemotherapy for high-risk soft tissue sarcoma is ongoing, with stat…
-
CLINICAL_TRIALS trial_result · 2020-10-09Clinical Trial Update: Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery [Phase 2, Phase 3]
Clinical trial update of a phase 2/3 study evaluating preoperative radiation therapy with or without combination chemotherapy or pazopanib b…
-
CLINICAL_TRIALS trial_result · 2020-09-29Clinical Trial Update: SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas [Phase 2]
Phase II trial of pembrolizumab (MK-3475) in advanced soft tissue and bone sarcomas completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-09-10Clinical Trial Update: A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma [Phase 1]
Phase 1 trial evaluating olaratumab in combination with doxorubicin and ifosfamide for advanced or metastatic soft tissue sarcoma has comple…
-
CLINICAL_TRIALS trial_result · 2020-09-02Clinical Trial Update: Trabectedin Maintenance Post 1st-line in STS [Phase 3]
Phase 3 trial update on trabectedin maintenance after first-line therapy in soft tissue sarcoma has been terminated.